Ziprasidone Pharmacology episode artwork

EPISODE · Jan 7, 2021 · 13 MIN

Ziprasidone Pharmacology

from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

On this episode of the Real Life Pharmacology Podcast, I cover ziprasidone pharmacology. Ziprasidone has dopamine blocking activity and is classified as a second generation antipsychotic. Ziprasidone tends to have lower metabolic syndrome risks compared to other antipsychotics like clozapine and olanzapine. QTc prolongation is a significant risk with ziprasidone and be aware of drug interactions and electrolyte imbalances that may increase this risk. I discuss important drug interactions on the podcast, be sure to check out my latest project which is a 200+ page book on managing drug interactions in primary care. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Episode metadata supplied by the publisher feed · Published Jan 7, 2021

Embed this episode

NOW PLAYING

Ziprasidone Pharmacology

0:00 13:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Real Life Pharmacology - Pharmacology Education for Health Care Professionals?

This episode is 13 minutes long.

When was this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode published?

This episode was published on January 7, 2021.

Can I download this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!